Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance HA-NA Compensation
2011

Influenza A Virus Resistance and Antigenic Variation

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): Hensley Scott E., Das Suman R., Gibbs James S., Bailey Adam L., Schmidt Loren M., Bennink Jack R., Yewdell Jonathan W.

Primary Institution: Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Hypothesis

Do some amino acid substitutions in hemagglutinin provoke compensatory mutations in neuraminidase to maximize viral fitness?

Conclusion

The study found that antibody-driven antigenic variation in hemagglutinin can lead to compensatory mutations in neuraminidase, resulting in drug resistance.

Supporting Evidence

  • Antibody-driven escape in hemagglutinin can lead to mutations in neuraminidase.
  • Compensatory mutations in neuraminidase can result in drug resistance.
  • The study analyzed 40 anti-HA mAb escape mutants.

Takeaway

When the flu virus changes to escape from antibodies, it can also change in a way that makes it resistant to drugs.

Methodology

Sequencing of HA and NA genes of 40 anti-HA mAb escape mutants and measurement of NA activity.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0015190

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication